SaveIN partners with Orthosquare to make dentistry affordable in India


New Delhi: SaveIN, a healthcare financing platform, has partnered with Orthosquare, a chain of dental clinics, to offer Care Now Pay Later (CNPL) options.

SaveIN will provide instant, zero-cost IMEs to thousands of Orthosquare patients at more than 100 clinics in 20 cities nationwide.

“We are building a network of quality healthcare providers to meet the needs of dental patients. Dental is a huge market and people are looking for a variety of procedures including dental work, cosmetic treatments, aligners and implants. We aim to make these treatments accessible and affordable through our 0% EMIs and we are thrilled to partner with a brand like Orthosquare,” said Jitin Bhasin, Founder of SaveIN.

SaveIN is a go-to platform for private healthcare and aims to expand to 5,000 healthcare outlets across the country by the end of this fiscal year, the company said.

The platform partners with health centers and individual institutions, creating India’s largest offline integrated healthcare ecosystem that enables hyper-local discovery of vetted healthcare providers all simplifying the experience and improving affordability through zero-cost IMEs.

“At Orthosquare, we pride ourselves on providing high quality, consistent and affordable dental care in all of our clinics and have treated over 5,000 patients over the past 13 years in business. We realize that dental costs are not covered by most insurance plans and incurs high expense for our patients.This is where we believe SaveIN’s Instant 0% IMEs will be a win-win solution for all stakeholders. looking forward to serving many more patients through this program and are very excited to partner with them,” said Dr. Kunal Shet, Founder and Director of Orthosquare Multispecialty Dental Clinic.

Catch all the company news and updates on Live Mint. Download the Mint News app to get daily market updates and live trade news.

More less

To subscribe to Mint Bulletins

* Enter a valid email

* Thank you for subscribing to our newsletter.


Comments are closed.